Trulieve Completes Redomicile to Delaware

TALLAHASSEE – Trulieve Cannabis Corp. completed its redomiciliation from British Columbia, Canada, to the State of Delaware, following a shareholder vote and a Final Order from the British Columbia Supreme Court. The redomicile took effect when the necessary filings were made effective by The Diamond State.

The ballot was decisive: 71,756,586 shares were cast in favor of the Delaware domestication, compared to 383,078 against and 50,472 abstentions, representing approximately 99.5% support among shares that registered a vote for the proposal, per a filing with the U.S. Securities and Exchange Commission.

“Redomiciling to the United States marks an exciting new chapter for our company, expanding access to U.S. investors and enhancing eligibility for broader index inclusion. We are thrilled to align our corporate structure with where we operate, invest, and serve our patients.”, said Kim Rivers, CEO of Trulieve.

Trulieve first announced the plan in May 2026, calling the domestication a step to bring the company’s legal home in line with the geography of its actual operations. The company holds vertically integrated Cannabis facilities across Florida, Georgia, Pennsylvania, and West Virginia. None in Canada.

Delaware has long been the default corporate jurisdiction for U.S. publicly traded companies, largely because of its well-developed body of corporate law and business-friendly governance structure. For Trulieve, a formal Delaware domicile removes barriers that Canadian corporate registration created around institutional investment mandates and stock index eligibility; even after the company had built an entirely U.S.-based operational footprint.

The redomicile arrived in the wake of Trulieve’s June 2026 uplist to the New York Stock Exchange, which made the Florida-based MSO the first U.S. Cannabis company to trade on a major American exchange. That listing, achieved through a restructuring that ring-fenced medical Cannabis operations from adult-use markets, expanded Trulieve’s visibility to a broader class of institutional investors. Delaware incorporation removes the cross-border legal complexity that remained after the NYSE listing, and the company confirmed the redomiciliation is not expected to cause any material change in the company’s business or operations.

The Delaware registration represents the capstone to a sequence of structural decisions that accumulated over the past year: from the Harvest deconsolidation and NYSE uplisting to the full alignment of the corporate wrapper with U.S. law. The near-unanimous shareholder vote reflects strong institutional confidence in that direction. The central question now is how index eligibility materializes in practice, and at what pace domestic incorporation accelerates inflows from funds that previously excluded the stock on jurisdictional grounds.